GLUE
Monte Rosa Therapeutics Inc
NASDAQ: GLUE · HEALTHCARE · BIOTECHNOLOGY
$20.39
+5.37% today
Updated 2026-05-06
Market cap
$1.50B
P/E ratio
—
P/S ratio
12.16x
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$4 – $26
Volume
1.1M
Monte Rosa Therapeutics Inc (GLUE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-31.20%
Operating margin
-1,788.00%
ROE
-16.90%
ROA
-7.64%
Debt/equity
0.16x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-8.02M | — | — | — |
| 2020 | $0.00 | $-35.88M | — | — | — |
| 2021 | $0.00 | $-73.96M | — | — | — |
| 2022 | $0.00 | $-108.50M | — | — | — |
| 2023 | $0.00 | $-135.35M | — | — | — |
| 2024 | $75.62M | $-72.70M | 89.26% | -107.26% | -96.14% |
| 2025 | $123.67M | $-38.63M | 93.24% | -43.83% | -31.23% |